Authors
Loading...
Research shows increased oncogenic mutations in hematopoietic stem cells of sickle cell disease mice, suggesting early intervention could mitigate risks of myelodysplastic syndrome.
Chi et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: